Treatment protocol (Gemcitabine + Docetaxel + Avastin)
Ministry of health of Ukraine
Name and location of the health care institution from which the statement was sent
MEDICAL DOCUMENTATION
Form of primary accounting documentation N 027-1/o
The order of the Ministry of Health of Ukraine was approved 10.10.2007 № 629
National
Cancer Institute
03022, Kyiv, 33/43 Lomonosova st,
EDRPOU CODE 02011976
AN EXTRACT
an extract from the medical card of an inpatient with a malignant neoplasm
November "15th” 2022
To: Zhytomyr region. , Malynsky district
Identifier: С212964 N: 14809/2022
Surname, first name, patronymic: ZHERLITSYNA ANASTASTYA STANISLAVIVNA
Sex: female
Date of birth (DD/MM/YYYY): 25/04/1976
The patient's registration address: (713 ;0 ) 30 Heroiv Krut st., Zhytomyr Region , Malynskyi District, Malyn city,
Type: town
The place of work (specialty): unknown
Group of primary accounting:
Date of hospitalization (DD/MM/YYYY): 27/09/2022
Date of discharge(DD/MM/YYYY): 28/09/2022
CODE ICD-10: C55 (34 unspecified part of the uterus)
Clinical group: 2
FINAL DIAGNOSIS
1. Clinical diagnosis: malignant neoplasm (ICD-10 code C55)
(48901) uterus
(3254) Leiomyosarcoma
Date of diagnosis: 8 /2022
Indices (p) TNM according to the 6th revision:
Т2 NO M1
The diagnosis is confirmed: histologically
Morphological conclusion № 48278 from 31/08/2022 (DD/MM/YYYY)
Transferred and accompanying diseases:
(code ICD-10)
(code ICD-10)
Chronic gastritis
01/09/2022: distant metastasis 19805-omentum
01/09/2022: distant metastasis 16001-liver
HOSPITAL
Hospitalization:
from 01/09/2022 until 02/09/2022 (DD/MM/YYYY) about:
- malignant neoplasm of of an unspecified part of the uterus (ICD-10 code C55)
Hospitalization: from 08/09/2022 until 09/09/2022 about:
- malignant neoplasm of of an unspecified part of the uterus (ICD-10 code C56)
Hospitalization: from 27/09/2022 until 28/09/2022 about: (ICD-10 code C55)
- malignant neoplasm of of an unspecified part of the uterus
CHRONOLOGY OF TREATMENT (DD/MM/YYYY)
Chemo-, hormone-, immunotherapy
| NI hosp. | Drug | Dose (Total) | Method of drug administration |
|---|---|---|---|
| 0. | from 04/10/2022 until 04/10/2022 Type:Chemotherapy Character: according to a radical program |
||
| - Gemzar | 2000.0 | intravenously | |
| 1. | from 01/09/2022 until 01/09/2022 Type:Chemotherapy Character: according to a radical program |
||
- Taxotere - Gemzar |
160.0 2000.0 |
intravenously intravenously |
|
| 2. | from 08/09/2022 until 08/09/2022 Type:Chemotherapy Character: according to a radical program |
||
| - Gemzar | 2000.0 | intravenously | |
| 3. | from 27/09/2022 until 27/09/2022 Type:Chemotherapy Character: according to a radical program |
||
- Taxotere - Gemzar |
160.0 2000.0 |
intravenously intravenously |
|
20. Special examination methods:
21. Recommendations at discharge:
The doctor who filled out the discharge: L A Proskurnya
Chief department: U V Ostapenko